David Daniel Schwartz, PhD
- Neuropsychology
- Pediatric Psychology
Pediatric Neuropsychologist
Professor, Department of Pediatrics, Psychology Division, Baylor College of Medicine
Phone:
832-822-3700
Languages: English
Office location:
Texas Medical Center
6701 Fannin Street
Houston, TX 77030
Get to know David Daniel Schwartz, PhD
Dr. Schwartz's main clinical and training interests are: neuropsychological assessment of children with chronic illness (e.g., type 1 diabetes, congenital heart conditions), and cognitive and psychosocial risk screening (including use of predictive analytics) to identify patients at risk for problematic medical adherence and deleterious health outcomes. His research is closely tied to his clinical work and is focused on 1) the relationship between neurocognitive and executive functioning and medical adherence (including illness-related risk-taking), 2) prediction of risk for complications of chronic illness (e.g., diabetic ketoacidosis), and 3) neurocognitive outcomes of chronic illness (e.g., chronic kidney disease, urea cycle disorders, and different rare genetic syndromes).
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Texas Children's Hospital | Fellowship | Pediatric Neuropsychology | 2006 |
| University of Delaware | PhD | Doctor of Philosophy | 2004 |
| Alfred I. DuPont Institute | Internship | Pediatric Psychology | 2004 |
Organizations
| Organization Name | Role |
|---|---|
| Academy of Distinguished Educators, Baylor College of Medicine | Member |
| American Academy of Clinical Health Psychology | Fellow |
| Clinical Practice in Pediatric Psychology (APA Journal) | Editorial Board |
Board Certification
Board Certified, American Board of Clinical Health Psychology
Honors and awards
- 2019
-
Norton Rose Fulbright Faculty Excellence Award
- 2014
-
Fulbright & Jaworski L.L.P. Faculty Excellence Award
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Schwartz DD. Neuropsychological Aspects of Type 1 Diabetes: Assessment and Clinical Implications. Invited chapter to appear in Maricle D (ed.), Understanding and Managing Neurodevelopmental Disorders in Children and Adolescents: A Pediatric Treatment Guide. Routledge, 2025. In Press.
Schwartz DD, Banuelos R, Uysal S, Vakharia M, Hendrix K, Fegan-Bohm K, Lyons S, Sonabend R, Dei-Tutu S. An Automated Risk Index for Diabetic Ketoacidosis in Pediatric Patients with Type 1 Diabetes: The RI-DKA. Clinical Diabetes, 2022;40(2):204–210. https://doi.org/10.2337/cd21-0070
Klouda L, Franklin WJ, Saraf A, Parekh DR, Schwartz DD. Neurocognitive and Executive Functioning in Adult Survivors of Congenital Heart Disease. Congenital Heart Disease, 2016. PMID: 27650247 DOI: 10.1111/chd.12409
Schwartz DD, Axelrad ME, Anderson BJ. Neurocognitive functioning in children and adolescents at the time of Type 1 diabetes diagnosis: Associations with glycemic control one year after diagnosis. Diabetes Care, 2014; 9: 2475-82. PMID: 24969580 DOI:10.2337/dc14-0103
Schwartz, DD, Axelrad ME, Anderson BJ. A psychosocial risk index for poor glycemic control in children and adolescents with Type 1 diabetes. Pediatric Diabetes, 2014; 15: 190–197. PMID: 24118977 DOI: 10.1111/pedi.12084
Schwartz DD, Cline VD, Axelrad ME, Anderson BJ. Feasibility, acceptability, and predictive validity of a psychosocial screening program for children and youth newly diagnosed with Type 1 diabetes. Diabetes Care, 2011; 34: 326-331. doi: 10.2337/dc10-1553
Schwartz DD, Axelrad ME. Healthcare partnerships for pediatric adherence: promoting collaborative management for pediatric chronic illness care. SpringerBriefs in Child Health. Springer International Publishing: Switzerland, 2015.